...
首页> 外文期刊>Intensivmedizin und Notfallmedizin >Die Überwachung der Leberfunktionen
【24h】

Die Überwachung der Leberfunktionen

机译:监测肝功能

获取原文
获取原文并翻译 | 示例
           

摘要

The relevance of liverndysfunction in the managementnof critically ill patients is increas-ningly being recognized. It hasnbeen found to affect mortality ofpatients with septic organ failurenin several studies. The increasingnprevalence of chronic liver diseasnamong intensive care patientsnadds importance to the issue ofnmonitoring the various aspects ofnliver function. An array of livernfunction tests as part of bloodnbiochemistry testing has longnbeen established. In the contextnof critical care and chronic liverndisease, however, they must beninterpreted cautiously. In addi-ntion, several dynamic tests of liv-ner function have been developed.nRelatively best explored are testsnbased on the hepatic eliminationnof indocyanine-green (ICG).nCommercially available systemsnanalyzing the plasma disappear-nance rate of ICG (ICG-PDR) arenbeing marketed but these para-nmeters also are difficult to inter-npret in the intensive care settingnand especially in patients withnchronic liver disease. ICG-PDRncorrelates with mortality in pa-ntients with septic organ dysfunc-ntion but studies investigating thenoutcome-oriented results of theranpeutic interventions directed bynthese parameters have not beennpublished. The possible relevancento intensive care management ofnseveral other dynamic tests ofnliver function, as well as intervenntional and ultrasonografic meth-nods to address liver perfusion,nare discussed in the article. Asyet, there is no single method tonmonitor the various aspects ofnliver function and no methodnwhose clinical value has beennproved. Clinicians therefore havento mostly rely on clinical judge-nment aided by a reasonable selec-ntion among existing monitoringntools.
机译:肝病功能在重症患者管理中的相关性日益得到认可。在几项研究中尚未发现它会影响败血性器官衰竭患者的死亡率。慢性肝病在重症监护患者中的患病率增加,对监测肝功能各个方面的问题也越来越重要。早已建立了一系列肝功能测试,作为血液生化测试的一部分。然而,在重症监护和慢性肝病的背景下,必须谨慎地解释它们。另外,已经开发了几种利弗纳功能的动态测试。n相对最理想的测试是基于吲哚菁绿(ICG)的肝消除。这些参数已经上市,但是在重症监护环境中尤其是慢性肝病患者也难以解释。 ICG-PDR与败血症性器官功能不全患者的死亡率相关,但有关以这些参数为指导的治疗性干预的结果导向型结果的研究尚未发表。本文未讨论与其他许多动态检查肝功能有关的重症监护管理的可能关系,以及干预和超声方法治疗肝脏灌注的相关性。但是,目前尚无单一方法可以监测肝功能的各个方面,也没有任何方法可以证明其临床价值。因此,临床医生大多无需依靠现有监测工具中合理选择的辅助临床判断。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号